4//SEC Filing
Yalamanchi Naveen 4
Accession 0001140361-22-023150
CIK 0001281895other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 9:07 PM ET
Size
14.0 KB
Accession
0001140361-22-023150
Insider Transaction Report
Form 4
Yalamanchi Naveen
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-13+47,745→ 47,745 totalExercise: $10.77Exp: 2032-06-13→ Common Stock (47,745 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001725743
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 9:07 PM ET
- Size
- 14.0 KB